Serum concentrations of infliximab may be detected up to six months after delivery, and may be predisposed to opportunistic infection and, as such, live vaccines are not recommended for children of patients on anti-TNF therapy in the first six months after birth [88,131]. The gene discussed is TNF; the disease is Opportunistic infection.